University of Cambridge > > euroscicon > The 2014 Regenerative Medicine Event: Stem Cell Reprogramming

The 2014 Regenerative Medicine Event: Stem Cell Reprogramming

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Speaker to be confirmed.

Talks include Progressing human pluripotent stem cell technologies for drug discovery and regenerative medicine by genome engineering Dr Peter Sartipy, Cellectis AB, Göteborg, Sweden Chemical Reprogramming of Human Amniotic FLuid Stem Cells to Pluripot

This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming. Progress towards therapeutic applications, and new insights into the molecular basis of pluripotency, differentiation, and transdifferentiation will be discussed in an informal setting with plenty of opportunity for networking. This event has CPD accreditation. This event is part of The 2014 Tissue Engineering Congress.

Who Should Attend Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students

Meeting Chair: Dr Christopher Ward, Senior Lecturer in Stem Cell Biology, The University ofManchester, UK

The deadline for abstract submissions for oral presentation is March 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at:

To view the full agenda see

This talk is part of the euroscicon series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity